Published in Gut Liver on March 01, 2015
The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol (2012) 2.53
Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol (2006) 1.87
Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver (2014) 1.38
Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol (N Y) (2012) 1.20
The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virol J (2013) 1.06
Cytomegalovirus infection in patients with new onset ulcerative colitis: a prospective study. Hepatogastroenterology (2012) 1.05
Diagnosis and treatment of ulcerative colitis with cytomegalovirus infection: importance of controlling mucosal inflammation to prevent cytomegalovirus reactivation. Intest Res (2014) 1.03
The cumulative colectomy rate in patients with cytomegalovirus-positive ulcerative colitis. Gut Liver (2015) 0.83
[Diagnostic guideline of intestinal tuberculosis]. Korean J Gastroenterol (2009) 1.01
Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future. Intest Res (2015) 1.00
Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea. Ann Coloproctol (2015) 0.89
Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea. Intest Res (2014) 0.88
Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study). Gut Liver (2016) 0.83
Successful treatment of postoperative fistula with infliximab in a patient with Crohn's disease. Intest Res (2014) 0.78
Long-term clinical outcomes of urban versus rural environment in Korean patients with Crohn's disease: results from the CONNECT study. J Crohns Colitis (2015) 0.78
Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease. Intest Res (2016) 0.76
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study. Yonsei Med J (2016) 0.76
Gastric lesions in patients with Crohn's disease in Korea: a multicenter study. Intest Res (2016) 0.76
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study. Gut Liver (2016) 0.75
Differences in Clinical Manifestations according to the Positivity of Interferon-γ Assay in Patients with Intestinal Tuberculosis. Gut Liver (2016) 0.75
[The Assessment of Korean Gastroenterology Research Achievements]. Korean J Gastroenterol (2009) 0.75
[An Unusual Case of Proctitis and Rectal Abscess due to Irritants by Artemisia asiatica Smoke (Ssukjwahun)]. Korean J Gastroenterol (2016) 0.75
Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease. Dig Dis Sci (2017) 0.75
The Clinical Characteristics and Prognosis of Crohn's Disease in Korean Patients Showing Proximal Small Bowel Involvement: Results from the CONNECT Study. Gut Liver (2017) 0.75